Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
Weed Week: The lazy stoner stereotype is a myth and this Aussie uni wants to study home grown cannabis
16 Sep 2022
Published by: Stockhead
Transformational acquisition and capital raise
01 Sep 2022
Published by: Next Investors
Bod reports decline in revenue and announces plan to acquire UK firm
01 Sep 2022
Published by: Cannabiz
Rise and Shine: Everything you need to know before the market opens
31 Aug 2022
Published by: Stockhead
ASX Health Stocks: Immutep now patently Japanese; Patrys preps Phase 1 trial of brain cancer drug
30 Aug 2022
Published by: Stockhead
Bod Australia, Alicanto Minerals chase equity injections
30 Aug 2022
Published by: Australian Financial Review
Weed Week: Legal use of medicinal cannabis in Australia on the rise, Lambert Initiative says
26 Aug 2022
Published by: Stockhead